UnitedHealth Analysts Slash Their Forecasts Following Q3 Results

Benzinga Earnings10-14 22:24

UnitedHealth Group Incorporated (NYSE:UNH) on Tuesday posted upbeat third-quarter results.

UnitedHealth Group reported quarterly earnings of $4.69 per share which beat the analyst consensus estimate of $4.15 per share. The company reported quarterly sales of $112.694 billion which beat the analyst consensus estimate of $111.403 billion.

UnitedHealth raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share from its previous range of $19.50 to $20. The revised outlook exceeds the analyst consensus estimate of $19.86.

The company also increased its GAAP earnings forecast to at least $19.50 per share, up from its previous guidance of $18.45 to $18.95. Analysts had expected $18.35 per share.

“Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them,” said Stephen Hemsley, chief executive officer of UnitedHealth Group.

UnitedHealth shares gained 3% to trade at $389.04 on Wednesday.

These analysts made changes to their price targets on UnitedHealth following earnings announcement.

  • Baird analyst Michael Ha maintained the stock with a Neutral and lowered the price target from $453 to $427.
  • Barclays analyst Andrew Mok maintained the stock with an Overweight rating and cut the price target from $441 to $440.

Considering buying UNH stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment